ArticlePlants (Basel, Switzerland)2025
Hyperparameter Optimization for Tomato Leaf Disease Recognition Based on YOLOv11m.
Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Attention-driven YOLOv11n-DeiT model for enhanced detection of tomato leaf diseases.Scientific reports · 2026Article
- Comparative hyperparameter optimization of object detection models for precision monitoring of cucumber beetles and similar insects on yellow sticky cards.Scientific reports · 2026Article
- Multi-objective Big Bang Big Crunch framework for reliable rice disease and variety classification with conditional calibration.PloS one · 2026Article
- Optimized YOLO architectures for efficient Kiwi detection in precision agriculture on embedded systems.Scientific reports · 2025Article
- Multi-Scale Feature Fusion Based RT-DETR for Tomato Leaf Disease Detection in Complex Backgrounds.Sensors (Basel, Switzerland) · 2025Article
- Crop leaf disease detection with additive gated convolution and hierarchical attention fusion.Scientific reports · 2025Article
- Optimized deep learning framework for pomegranate disease detection using nature-inspired algorithms.Plant methods · 2025Article
- TriPerceptNet: a lightweight multi-scale enhanced YOLOv11 model for accurate rice disease detection in complex field environments.Frontiers in plant science · 2025Article
- Cotton pest and disease diagnosis via YOLOv11-based deep learning and knowledge graphs: a real-time voice-enabled edge solution.Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The automated recognition of disease in tomato leaves can greatly enhance yield and allow farmers to manage challenges more efficiently. This study investigates the performance of YOLOv11 for tomato leaf disease recognition. All accessible versions of YOLOv11 were first fine-tuned on an improved tomato leaf disease dataset consisting of a healthy class and 10 disease classes. YOLOv11m was selected for further hyperparameter optimization based on its evaluation metrics. It achieved a fitness score of 0.98885, with a precision of 0.99104, a recall of 0.98597, and a mAP@.5 of 0.99197. This model underwent rigorous hyperparameter optimization using the one-factor-at-a-time (OFAT) algorithm, with a focus on essential parameters such as batch size, learning rate, optimizer, weight decay, momentum, dropout, and epochs. Subsequently, random search (RS) with 100 configurations was performed based on the results of OFAT. Among them, the C47 model demonstrated a fitness score of 0.99268 (a 0.39% improvement), with a precision of 0.99190 (0.09%), a recall of 0.99348 (0.76%), and a mAP@.5 of 0.99262 (0.07%). The results suggest that the final model works efficiently and is capable of accurately detecting and identifying tomato leaf diseases, making it suitable for practical farming applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.